# Kodiak Stock Gains 142% as New Eye Drugs Take Aim at Regeneron’s Eylea

> **Open Intelligence Dossier** · First detected: 2026-09-28 16:20 UTC · Category: Business

## Executive Summary
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
&quot;Kodiak Stock Gains 142% as New Eye Drugs Take Aim at Regeneron’s Eylea&quot; is generating significant coverage in the Business category, with 2 articles from 2 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Yahoo Finance and Barron&#039;s. PULSE measures a story&#039;s velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE&#039;s extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Yahoo Finance | Why Kodiak Sciences Skyrocketed Today | [Source Link](https://news.google.com/rss/articles/CBMinwFBVV95cUxOWDIzWjRFcWxsZXVMRDFfNUhKaFBiUUxsUWJtUVZ6Si1VMDVhUG9yb3hpYnoyRnJKN3JCb1NxNHRaLWdCdkFlU3M3MktSNVplZmRuNTJiNmRZRWlwWElpcTlPbzRwSC0xSVUxeW9EWVR2UGNYeExoUmFyMy01OU5tSTFqU1gyTmpNQ3FoT3ZVbDA2ZldkUjlRY0Y1VFp2UDA?oc=5) |
| Yahoo Finance | Why Did KOD, RGEN, BIIB Stocks Rise To 52-Week Highs? | [Source Link](https://news.google.com/rss/articles/CBMidkFVX3lxTE9QS2Y4UTc0clQ3YWlfcnVlUnQ1ZnVCVlZyUHJGTmZQSXRGTXJ2TWtWaDFqczhhVXZaQlJvNktEaDZjRGpXangwOXI4NU8wV0p0bzRubmR5U2dxX0QxRWJOUjBmUmpwd25pbnN6b01xOFRrVVFIbGc?oc=5) |
| Barron's | Kodiak Stock Gains 142% as New Eye Drugs Take Aim at Regeneron’s Eylea | [Source Link](https://news.google.com/rss/articles/CBMiiAFBVV95cUxPMkxGVjVidDVxdHRPZk9LcDEzTHViNFNLblBuUHVrSXQyakd0cjhveXVQVUVTNU5JNkMyclVWNXo1VmtwOXg2SE04azhVdmRlN1hZR2psZ3lWa3dVY3J1V0FzV25JcDdVak9kOUxTbi0wUlVJeDdPZ2o5dWI5WDNGU252MnVCTmNo?oc=5) |

---
*Canonical Source: https://pulse.byoaiapps.com/trend/2026-09-28/kodiak-stock-gains-142-as-new-eye-drugs-take-aim-at-regeneron-s-eylea*
